Your browser doesn't support javascript.
loading
Clinical Application Guidelines on Chinese Patent Medicine in Treatment of Ulcerative Colitis (Condensed Edition, 2022) / 胃肠病学
Chinese Journal of Gastroenterology ; (12): 17-26, 2023.
Article in Chinese | WPRIM | ID: wpr-1016045
ABSTRACT
Ulcerative colitis (UC) is a dominant disease that can be treated with traditional Chinese medicine, and Chinese patent medicine is an important part of traditional Chinese medicine. However, there are still many cases of non-standard drug use in the clinical treatment of UC. Clinical Application Guidelines for Dominant Diseases Treated with Chinese Patent Medicine Standardization Project Team convened experts on traditional Chinese medicine, Western medicine, pharmacology, and methodology to compile this guideline. This guideline formulated recommendations for oral and (or) clyster treatment of UC in different severities and goals of treatment, in order to provide normative suggestions for clinicians to rationally use Chinese patent medicines in UC.

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Journal of Gastroenterology Year: 2023 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Journal of Gastroenterology Year: 2023 Type: Article